Free Trial

Merck KGaA (OTCMKTS:MKGAF) Stock Price Down 3.9% - Here's What Happened

Merck KGaA logo with Medical background

Merck KGaA (OTCMKTS:MKGAF - Get Free Report)'s share price was down 3.9% during trading on Thursday . The company traded as low as $129.47 and last traded at $129.47. Approximately 162 shares traded hands during trading, a decline of 85% from the average daily volume of 1,081 shares. The stock had previously closed at $134.71.

Merck KGaA Trading Up 0.0%

The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. The company has a fifty day simple moving average of $133.99 and a 200-day simple moving average of $139.59. The company has a market capitalization of $17.42 billion, a PE ratio of 20.57 and a beta of 0.96.

Merck KGaA Company Profile

(Get Free Report)

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

Recommended Stories

Should You Invest $1,000 in Merck KGaA Right Now?

Before you consider Merck KGaA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Merck KGaA wasn't on the list.

While Merck KGaA currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

ALERT: Big Tech Earnings – Watch Before Wednesday
ACT FAST! Congress is Dumping these 3 Stocks
3 “Boring” Mega Cap Stocks to Turn Into Pure Profit

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines